Nasdaq
$36.40▼ 0.30%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.68BShares out 46.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
17- 2d agoPre-market26.10.23 21:014Ownership#●●●
Azenta, Inc.
Insider Martin D. Madaus of Azenta, Inc. filed a Form 4 on October 23, 2026, reporting changes in beneficial ownership of securities as of October 22, 2026. This filing serves as a standard disclosure of executive stock transactions.…more
$36.40-0.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7Pre-market26.10.07 21:018-KKey event
Azenta, Inc.
Azenta, Inc. has approved a restructuring plan to consolidate its North American laboratory network and reduce its workforce within the Multiomics segment to improve operating efficiency. The company expects to incur aggregate pre-tax charges of approximately $11.0 million to $13.0 million, while anticipating annualized cost savings of approximately $11.0 million. The plan is expected to be substantially completed by March 31, 2027.…more
$36.40-0.30%vs prev closeView filingShare - 9.23Regular26.09.23 23:244Ownership
Azenta, Inc.
Insider Martin D. Madaus of Azenta, Inc. reported a change in beneficial ownership of securities as of September 22, 2026. This filing formalizes the disclosure of stock holdings changes by the executive via Form 4.…more
$36.40-0.30%vs prev closeView filingShare
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.4Pre-market26.09.04 21:05Bullish#●●●
Azenta Fully Repays $35M Vendor Loan Tied to B Medical Systems Sale Ahead of Maturity…more
Azenta has received full repayment of a $35 million vendor loan related to the sale of B Medical Systems ahead of its scheduled maturity. This early recovery of capital is expected to strengthen the company's cash position and financial stability.…more
$36.40-0.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 8.24Pre-market26.08.24 21:06
●●●●●●●● ●●●●● ●●●●●●
Azenta has appointed board member Martin Madaus as interim CEO following the resignation of John Marotta. The company also reaffirmed its previously issued revenue guidance for the fourth quarter of fiscal 2026.…more
$36.40-0.30%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report